In humans, increased tumor sc-IgGs were found to be associated with poor breast cancer patient outcomes (35) and high levels of MMP3-/MMP12-cleaved IgG were detected in sera from inflammatory bowel diseases patients, who did not respond to anti-TNFα therapy (10). Here, MMP12 is linked to inflammatory bowel disease.